Abstract:AIM To prepare anti-c-Kit monoclonal antibodies and characterize their specificity of epitope recognition. METHODS cDNA encoding human c-Kit extracellular domain was constructed into a procaryotic expression vector pQE30 and the correctness of the reconstructed plasmid pQE30-KitD4-5 was verified by sequencing. The plasmid was transformed into E.coli M15 strain. Recombinant 6 x His pQE30-KitD4-5 was expressed after induction by IPTG for 4 h. Then SDS-PAGE results suggested that the products mainly formed inclusion bodies. The fusion protein was further purified with Ni-NTA-His affinity chromatography and then used to immunize BALB/c mice. The hybridomas were achieved by fusing the immunized spleen cells with the Sp2/0 myeloma cell line. The positive clones were screened by FCM with CHO-hKit cells. Hybidoma clones secreting anti-c-Kit antibodies were further subcloned and investigated for their biological activities by Western blot, rapid isotyping analysis and FCM. RESULTS Recombinant human c-Kit fusion proteins were in vitro expressed and purified to be used as immunogen. One stable hybridoma cell line, which continuously secrets specific anti-c-Kit monoclonal antibody ((SRJ1)) was established. The biological activity studies showed that the monoclonal antibody recognized the natural c-Kit expressed on the Kasumi leukemia cell line, but failed to bind to the normal human peripheral blood cells. Interestingly, this monoclonal antibody failed to recognize a subpopulation of Kasumi cells that is reactive with the commercial anti-c-Kit mAb Ab81 suggesting that the c-Kit expressed by this subpopulation contains some sequencial and/or structural aberrations that are distinguishable by mAb SRJ1. CONCLUSION With an immunization procedure using purified recombinant human c-Kit fusion proteins. a hybridoma cell line continuously and stably secreting anti-c-Kit monoclonal antibody has been established. The monoclonal antibody SRJ1 specifically recognizes human c-Kit expressed on the leukemia cells, and may provide a novel approach to analyze the possible structural variations of c-Kit expressed by different cells.

Preparing Monoclone Antibody of Human Thymidine Kinase

[Preparation and Characterization of Monoclonal Antibody Against Human Telomeric Repeat Binding Factor 1].

Preparation of monoclonal antibody against human tissue kallikrein and development of an ELISA kit

[Preparation and Characterization of a Monoclonal Antibody Against Human C-Kit].

Development of a Novel Recombinant Full-Length IgY Monoclonal Antibody against Human Thymidine Kinase 1 for Automatic Chemiluminescence Analysis on a Sandwich Biotin-Streptavidin Platform for Early Tumour Discovery

Preparation and Identification of Cloning Antibody of Antigen Relative to Kidney Tumor

Preparing and identifying a monoclonal antibody against human colorectal carcinoma

[Preparation and Identification of Monoclonal Antibodies Against Chicken Cell Cycle Checkpoint Kinase 2 (Cchk2)].

Purification for Recombined Protein of Human Truncated Midkine and Polyclonal Antibody Preparation

Preparation and preliminary characterization of rabbit monoclonal antibodies against human midkine

Preparation and characterization of monoclonal antibodies to human FKBP52 molecule

Preparation and Characterization of A Monoclonal Antibody Against Cklf1 Using Dna Immunization with in Vivo Electroporation

Development of Monoclonal Antibodies Against Cdc2-related Protein Kinase PFTK1

Preparation and Characterization of Monoclonal Antibodies Against Recombinant Human NDPK-A

PREPARATION OF MONOCLONAL-ANTIBODIES AGAINST THYROID-STIMULATING HORMONE (TSH)

Prepartion and Identification of the Monoclonal Antibody to CTGF

Expressing Human Thymidine Kinase in E.coli

Preparation and characterization of monoclonal antibodies against human cytokeratin 19 fragment antigen 21-1

Preparation and Characterization of Monoclonal Antibodies Against Adenylate Kinase

Preparation and Characterization of Monoclonal Antibodies Against Trypsingen Activation Peptides

Preparation and characterization of monoclonal antibody against hTSC29 pep-tides